Impact on the Incremental Cost-Effectiveness Ratio of Using Alternatives to EQ-5D in a Markov Model for Multiple Sclerosis
Crossref DOI link: https://doi.org/10.1007/s40273-016-0421-0
Published Online: 2016-06-09
Published Print: 2016-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Versteegh, Matthijs
License valid from 2016-06-09